Rein Therapeutics posts LTI-03 presentation; no specifics in filing

Rein Therapeutics, Inc.

On September 4, 2026, Rein Therapeutics published a presentation on LTI-03 on its IR website.
The presentation is attached as Exhibit 99.1; the provided text does not include its content.
No financial, clinical, or regulatory updates are disclosed in the 8-K body.

item 7.01 item 9.01

Rein Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-383726

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.